The Mark Foundation for Cancer Research and the Medical Advisory Board of Gabrielle’s Angel Foundation for Cancer Research are pleased to formally announce a promising new research initiative, the Gabrielle’s Angel Foundation – Mark Foundation Collaborative Grant Award. Our Foundations have established this initiative which will fund collaborative research led by investigators currently or previously funded by Gabrielle’s Angel Foundation. We first announced this award at our annual Medical Symposium in May and believe it will be a wonderful opportunity for us to re-invest in your work while helping to accelerate progress by bringing together scientists and institutions for collaboration.
In keeping with the mission of our Foundation, these projects should be focused on clinically relevant research in hematologic malignancies. This opportunity is for conventional research projects only, we will not be accepting applications for integrative projects. Work that could be translated into a clinical setting within a few years will be prioritized over that of a more fundamental, though scientifically sound, nature. As we anticipate that all of the scientists applying under this initiative will have an outstanding track record, we will grade these proposals primarily on the significance of the science proposed and the likelihood that it will be successful in generating discoveries.
This award offers a team of 2–3 researchers $250,000.00 per year for a total of $500,000.00 over two years. Teams of up to 3 investigators are permitted, but at minimum 2 of the 3 must be prior Medical Research Award grantees and the project leader on all proposals must be a current/former Gabrielle’s Angel Foundation grantee. Please view this list for names and contact information of current/former grantees for outreach purposes.
Gabrielle’s Angel Foundation continues its tradition of funding innovative and insightful medical research on hematologic malignancies. To date, the Foundation has committed nearly $40 million in Medical Research Awards in support of faculty members at the nation’s leading institutions.
The Mark Foundation for Cancer Research actively partners with scientists, research institutions, and philanthropic organizations around the world to accelerate research that will transform the prevention, diagnosis, and treatment of cancer. Since 2017, The Mark Foundation has awarded more than $200 million in grants and venture investments that support groundbreaking science carried out by individual investigators, multi-disciplinary teams, and early-stage companies across the globe.
Our foundations share a mission to cure cancer as well as a commitment to funding only the highest caliber scientists, and hope, through this award, to further accelerate the extraordinary progress being made in cancer research today. On behalf of The Mark Foundation, Gabrielle’s Angel Foundation, and the President and Co-Founder of Gabrielle’s Angel Foundation, Denise Rich, we look forward to receiving your submissions.
Stephen D. Nimer, M.D., Director
Sylvester Comprehensive Cancer Center
University of Miami Miller School of Medicine
Ryan Schoenfeld, Ph.D.
Chief Executive Officer
The Mark Foundation for Cancer Research